The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trick-MCC: Final results from the proof-of-concept investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory Merkel cell carcinoma (NCT06056895).
 
Natalie Miller
No Relationships to Disclose
 
Grete Ambrazeviciute
No Relationships to Disclose
 
Tomas Bencomo
No Relationships to Disclose
 
Kate Biese
No Relationships to Disclose
 
Wenwen Chen
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Candice Church
No Relationships to Disclose
 
Sumia Dakhil
Employment - UW
 
Priscilla Kim
No Relationships to Disclose
 
Samantha Kiriluk
No Relationships to Disclose
 
Rima Kulikauskas
No Relationships to Disclose
 
Carina Morningstar
No Relationships to Disclose
 
Vivian Nguyen
No Relationships to Disclose
 
Thomas Pulliam
Research Funding - Bristol Myers Squibb (Inst)
 
Samantha Szumski
Employment - University of Washington
 
Joshua Veatch
Stock and Other Ownership Interests - Lyell Immunopharma; Novo Nordisk
Research Funding - Gilead Sciences
Patents, Royalties, Other Intellectual Property - There are 3 patents on which I am an inventor that have been licensed
 
Paul Nghiem
Leadership - Society for Investigative Dermatology (SID)
Honoraria - UpToDate
Consulting or Advisory Role - Almirall
Research Funding - Incyte (Inst)
Patents, Royalties, Other Intellectual Property - Patent filed: "Merkel cell polyomavirus T antigen-specific TCRs and uses thereof" (Inst); Patent pending for high affinity T cell receptors that target the Merkel polyomavirus.
 
Shailender Bhatia
Honoraria - Bristol-Myers Squibb; Incyte; Replimune
Consulting or Advisory Role - Bristol Myers Squibb; Incyte; Replimune
Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Incyte (Inst); Merck (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - Regeneron